Results 1 to 10 of about 396,888 (322)
Asenapine: an atypical antipsychotic with atypical formulations [PDF]
Therapeutic Advances in Psychopharmacology, 2021 Asenapine is a second-generation (atypical) antipsychotic medication not available in a pill that can be swallowed; rather, it is commercialized in sublingual and transdermal formulations.
Meghan Musselman +2 more
doaj +5 more sources
Atypical Antipsychotic Medications and Hyponatremia in Older Adults: A Population-Based Cohort Study [PDF]
Canadian Journal of Kidney Health and Disease, 2016 Background: A number of case reports have suggested a possible association between atypical antipsychotic medications and hyponatremia. Currently, there are no reliable estimates of hyponatremia risk from atypical antipsychotic drugs.
Sonja Gandhi +6 more
doaj +3 more sources
Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five cases [PDF]
Annals of General Psychiatry, 2010 Background Atypical antipsychotic drugs have been reported to cause fewer incidences of extrapyramidal side effects (EPS) than typical antipsychotic drugs, but adverse events such as akathisia have been observed even with atypical antipsychotic drugs ...
Hashimoto Kenji, Furuse Tsutomu
doaj +3 more sources
Oral discomfort and health behavior of patients with typical vs. atypical antipsychotic drugs [PDF]
Frontiers in PsychiatryIntroductionPsychiatric patients suffer from oral diseases and side effects of antipsychotic medication. In particular, the typical antipsychotic drugs may cause severe hyposalivation with subsequent oral symptoms.
Jukka H. Meurman +2 more
doaj +2 more sources
Can atypical antipsychotic drugs cause hepatotoxicity? [PDF]
European Psychiatry, 2021 Introduction Neuropsychiatric drugs account for 16% of drugs that can lead to hepatotoxicity and psychiatric patients can have multiple comorbidities that can increase the incidence of liver disorders such as alcoholism, drug abuse and polymedication ...
R. André, C. Sereijo, M. Abreu
doaj +2 more sources
Neuropsychiatric Disease and Treatment, 2012 Naoki Goto1, Reiji Yoshimura1, Shingo Kakeda2, Joji Nishimura2, Junji Moriya2, Kenji Hayashi1, Asuka Katsuki1, Hikaru Hori1, Wakako Umene-Nakano1, Atsuko Ikenouchi-Sugita1, Yukunori Korogi2, Jun Nakamura11Department of Psychiatry, University of ...
Goto N +11 more
doaj +2 more sources
Effect of Atypical Antipsychotic Medications on the Risk of Obstructive Sleep Apnea in Individuals With Schizophrenia [PDF]
Sleep Medicine Research, 2022 Background and Objective Weight gain and obesity could be side effects of taking atypical antipsychotic medications. They are major risk factors for obstructive sleep apnea.
Habibolah Khazaie +5 more
doaj +1 more source
Atypical Antipsychotic Use in Patients With Dementia: Managing Safety Concerns
American Journal of Psychiatry, 2012 Martin H. Steinberg +1 more
openalex +3 more sources
Jurnal Farmasi Sains dan Komunitas, 2021 Psychotic disorders create a burden on the government, family, and society because of decreasing patient productivity. The use of atypical-atypical and atypical-typical antipsychotic combinations is one of the most commonly used combinations for patients
Arya Dibyo Adisaputra +2 more
doaj +1 more source
Effect of Atypical Antipsychotic Usage at Therapeutic Doses on Daytime Sleepiness
Journal of Advanced Research in Natural and Applied Sciences, 2023 The aim of this study is to determine the effect of using atypical antipsychotic drug usage at therapeutic doses on daytime sleepiness. One hundred twenty volunteers who met the inclusion-exclusion criteria were divided into two equal groups.
Birol Topcu +2 more
doaj +1 more source